Singhana Burapol, Chen Aaron, Slattery Patrick, Yazdi Iman K, Qiao Yang, Tasciotti Ennio, Wallace Michael, Huang Steven, Eggers Mitch, Melancon Marites P
Department of Interventional Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
J Mater Sci Mater Med. 2015 Mar;26(3):124. doi: 10.1007/s10856-015-5460-0. Epub 2015 Feb 18.
To determine the feasibility of infusing resorbable inferior vena cava (IVC) filter with iodine-based contrast agents to produce a radiopaque, computed tomography (CT)-visible IVC filter. Infused poly(p-dioxanone) (PPDO) was obtained by incubating PPDO in different concentrations of 4-iodobenzoyl chloride (IBC) and 2,3,5-triiodobenzoic acid (TIBA). Characterizations of infused and nascent PPDO were done using elemental analysis, micro-CT, tensile strength analysis, scanning electron microscopy, and differential scanning calorimetry. Elemental analysis showed percentage loading of 1.07 ± 0.08 for IBC and 0.73 ± 0.01 for TIBA. The iodine loading remained the same within 2 weeks for TIBA but decreased to about 80 % with IBC when subjected to physiological conditions. Micro-CT images showed increased attenuation of the infused PPDO compared with the nascent PPDO. The Hounsfield unit values for infused and nascent sutures were 110 ± 40 and 153 ± 53 for PPDO infused with 2 mg/mL IBC and TIBA, respectively, but only 11.35 ± 2 for nascent PPDO. In contrast the HU for bone was 116 ± 37. Tensile strength analysis showed maximum loads of 1.01 ± 0.43 kg and 10.02 ± 0.54 kg for IBC and TIBA, respectively, and 10.10 ± 0.64 kg for nascent PPDO. Scanning electron microscopy showed that the morphology of the PPDO surface did not change after coating and preliminary cytotoxicity assay showed no killing effect on Hela cells. PPDO infused with a contrast agent is significantly more radiopaque than nascent PPDO on micro-CT imaging. This radiopacity could allow the position and integrity of infused resorbable IVC filter to be monitored while it is in place, thus increasing its safety and efficacy as a medical device.
为确定向可吸收的下腔静脉(IVC)滤器中注入碘基造影剂以产生不透射线的、计算机断层扫描(CT)可见的IVC滤器的可行性。通过将聚对二氧环己酮(PPDO)在不同浓度的4-碘苯甲酰氯(IBC)和2,3,5-三碘苯甲酸(TIBA)中孵育来获得注入造影剂的PPDO。使用元素分析、微型CT、拉伸强度分析、扫描电子显微镜和差示扫描量热法对注入造影剂的PPDO和未处理的PPDO进行表征。元素分析显示,IBC的负载百分比为1.07±0.08,TIBA的负载百分比为0.73±0.01。TIBA的碘负载在2周内保持不变,但在生理条件下,IBC的碘负载下降至约80%。微型CT图像显示,与未处理的PPDO相比,注入造影剂的PPDO的衰减增加。对于注入2 mg/mL IBC和TIBA的PPDO,注入造影剂的缝线和未处理的缝线的亨氏单位值分别为110±40和153±53,但未处理的PPDO仅为11.35±2。相比之下,骨骼的亨氏单位值为116±37。拉伸强度分析显示,IBC和TIBA的最大负载分别为1.01±0.43 kg和10.02±0.54 kg,未处理的PPDO的最大负载为10.10±0.64 kg。扫描电子显微镜显示,PPDO表面涂层后形态未发生变化,初步细胞毒性试验显示对Hela细胞无杀伤作用。在微型CT成像中,注入造影剂的PPDO比未处理的PPDO的射线不透性明显更高。这种射线不透性可使注入造影剂的可吸收IVC滤器在位时其位置和完整性得到监测,从而提高其作为医疗器械的安全性和有效性。